JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on August 11, 2006; DOI: 10.1124/jpet.106.109256


0022-3565/06/3192-847-856$20.00
JPET 319:847-856, 2006
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.106.109256v1
319/2/847    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gomez-Pinilla, P. J.
Right arrow Articles by Pozo, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gomez-Pinilla, P. J.
Right arrow Articles by Pozo, M. J.

GASTROINTESTINAL, HEPATIC, PULMONARY, AND RENAL

Melatonin Treatment Reverts Age-Related Changes in Guinea Pig Gallbladder Neuromuscular Transmission and Contractility

Pedro J. Gomez-Pinilla, Cristina Camello-Almaraz, Rosario Moreno, Pedro J. Camello, and María J. Pozo

Department of Physiology, Nursing School, University of Extremadura, Caceres, Spain

Received for publication June 9, 2006
Accepted August 9, 2006.


    Abstract
 Top
 Abstract
 Materials and Methods
 Results
 Discussion
 References
 
The incidence of gallbladder illness increases with age, but the altered mechanisms leading to gallbladder dysfunction are poorly understood. Here we determine the age-related alterations in gallbladder contractility and the impact of melatonin treatment. Isometric tension changes in response to electrical field stimulation and to agonists were recorded from guinea pig gallbladder muscle strips. [Ca2+]i was determined by epifluorescence microscopy in fura-2 loaded isolated gallbladder smooth muscle cells, and F-actin content was quantified by confocal microscopy. Aging reduced neurogenic contractions, which was associated with the impairment of nitrergic innervation and with increased responsiveness of capsaicin-sensitive relaxant nerves, possibly involving calcitonin gene-related peptide. Melatonin treatment for 4 weeks restored neurogenic responses to normal values, with an associated recovery of nitrergic function and the disappearance of the capsaicin-sensitive component. Aging also reduced the contractile responses to cholecystokinin and Ca2+ influx. The impaired contractility only correlated with diminished Ca2+ mobilization in response to activation of Ca2+ influx. Melatonin improved contractility and increased smooth muscle F-actin content without changing Ca2+ homeostasis. In conclusion, aging impairs gallbladder function as the result of changes in the inhibitory neuromodulation of smooth muscle contractility and the reduction in the myogenic response to contractile agonists. Impaired contractility seems to be related to decreased Ca2+ influx and damage of contractile proteins. Melatonin significantly ameliorated these age-related changes.


Population aging was one of the most distinctive demographic events of the 20th century, and according to the increase in the mean life expectancy, the elderly population will constitute 20% of the world population in the next 50 years (Centers for Disease Control and Prevention, 2003Go). Aging is understood to be mainly a slow, gradual, and passive process influenced by the interplay of multiple genetic and environmental factors. It is widely accepted that aging is not a disease, but the borderline between pathological and normal aging is quite narrow. Although there are many kinds of "nondisease" aging manifestations, including blood vessel stiffening, skin slacking, and joint stiffening, the molecular structures of aged organisms are abnormal (Bailey, 2001Go). These molecular abnormalities could be responsible for the increase in the incidence and prevalence in the elderly of the so-called age-related diseases such as neurodegenerative disorders (Troulinaki and Tavernarakis, 2005Go), cardiovascular disease (Ferrari et al., 2003Go), diabetes (Winer and Sowers, 2004Go), and incontinence (Nasr and Ouslander, 1998Go).

Regarding the gastrointestinal (GI) tract, the prevalence of dysfunctions related to motility is higher in older than in younger adults (Camilleri et al., 2000Go). However, there are very few studies concerning the cellular and molecular mechanisms whose alteration could be responsible for such dys-functions in aging. Thus, it has been reported that neuronal loss occurs with age in the myenteric plexus of the GI tract in several species including human (Gomes et al., 1997Go). However, it is unclear whether cell death affects all classes of myenteric neurons nonselectively or is confined to specific phenotypes (Wade and Cowen, 2004Go). Another important component that could be affected by aging, leading to contractility impairment, is smooth muscle itself. In this regard, information regarding the putative changes in cellular mechanisms of smooth muscle contraction is scanty (Bitar and Patil, 2004Go). Acetylcholine (ACh)-induced contractile responses are impaired in colon (Roberts et al., 1994Go), which could be due to the limited cell length distribution found in aged-animals but also to alteration of the intracellular cell signaling pathways related to activation of protein kinase C and cytoskeleton reorganization (Bitar, 2003Go). There is little information regarding the possible changes in Ca2+ homeostasis during aging in smooth muscle in general and gastrointestinal smooth muscle in particular, in which it has been described as an aged-related decline in the L-type Ca2+ currents both in rat and human colon smooth muscle cells (Xiong et al., 1993Go, 1995Go).

Knowledge of the molecular mechanisms involved in aging is required for development of strategies to preserve the quality of life of the increasingly aging population. Degenerative changes associated with aging have been related to progressive damage by reactive oxygen and nitrogen species in those situations in which the antioxidative defense system fails to eliminate them (Sohal and Allen, 1990Go). Recently, melatonin, the main hormone of the pineal gland, was proposed as a protective agent against macromolecular destruction associated with longevity (Reiter et al., 1996Go). The protective effects of melatonin could be related to the ability of the hormone to synchronize circadian rhythms and thereby to reduce biological stress, as well as to its direct free radical scavenging activity and its indirect antioxidants properties (Reiter et al., 2002Go).

In the current study we explored aged-related alterations of neuromuscular transmission, gallbladder contractility, and smooth muscle Ca2+ homeostasis. Our results show that aging-induced gallbladder impairment is primarily related to changes in the inhibitory innervation of the organ and to a decrease in the myogenic response to excitatory hormones and neurotransmitters. Melatonin treatment reversed the functional impairment caused by aging at the level of both the neuromuscular transmission and the myogenic contractility despite being ineffective in the restoration of Ca2+ homeostasis.


    Materials and Methods
 Top
 Abstract
 Materials and Methods
 Results
 Discussion
 References
 
Tissue Preparation. Gallbladders were removed from 4- and 20-month-old female guinea pigs after deep halothane anesthesia and cervical dislocation and were immediately placed in cold Krebs-Henseleit solution (for composition, see Solutions and Drugs) at pH 7.35. The gallbladder was opened from the end of the cystic duct to the base and trimmed of any adherent liver tissue. After the preparation was washed with the nutrient solution to remove residual bile, the mucosa was carefully dissected away.

A group of aged animals was treated orally with melatonin (2.5 mg/kg/day). Melatonin was dissolved in glucose solution (1.5%) and placed in the oropharynx by a syringe. This treatment was applied daily at the same time, just before the light in the animal house was switched off (7:00 PM). All of the experiments were conducted according to the guidelines of Animal Care and Use Committees of the University of Extremadura.

Measurement of Melatonin in Serum. Melatonin levels were determined in the different age groups by using a commercial radioimmunoassay kit (IBL, Hamburg, Germany), according to the manufacturer's instructions. The kit consisted of 125I-labeled melatonin (0.68 µCi/ml), rabbit anti-melatonin serum, melatonin standards, delipidizing agent, assay buffer, precipitating antiserum, and controls (lyophilized plasma samples). Results were expressed in picograms per milliliter.

Contraction Recording of Guinea Pig Gallbladder Smooth Muscle Strips. Gallbladder strips (measuring ~3 x 10 mm) were placed vertically in a 10-ml organ bath filled with Krebs-Henseleit solution maintained at 37°C and gassed with 95% O2-5% CO2. Isometric contractions were measured using force displacement transducers that were interfaced with a Macintosh computer using a MacLab hardware unit and software (ADInstruments, Colorado Springs, CO). The muscle strips were placed under an initial resting tension equivalent to a 1.5-g load and allowed to equilibrate for 60 min, with solution changes every 20 min. Every strip coming from a given animal was used in a different experimental protocol.

Intrinsic nerves were activated by electrical field stimulation (EFS) with a pair of external platinum ring electrodes (0.7 mm in diameter) connected to a square-wave stimulator (Cibertec CS9/3BO) programmed through Scope software application from MacLab (ADInstruments). Trains of stimuli (0.3-ms duration, 5–40 Hz, 350-mA current strength) were delivered for 10 s at 3-min intervals. After construction of a frequency-response curve and to pharmacologically dissect the neurogenic responses, antagonists were added to the organ bath for 20 min, and then the EFS protocols were repeated. In some experiments, the contractile effects of ACh, cholecystokinin (CCK), KCl, and Ca2+ restoration after intracellular Ca2+ store depletion were tested.

Cell Isolation. Gallbladder smooth muscle cells were dissociated enzymatically using a previously described method (Pozo et al., 2002Go). In brief, the gallbladder was cut into small pieces and incubated for 34 min at 37°C in enzyme solution (for composition see Solutions and Drugs) supplemented with 1 mg/ml bovine serum albumin (BSA), 1 mg/ml papain, and 1 mg/ml 1,4-dithio-DL-threitol. Next, the tissue was transferred to fresh enzyme solution containing 1 mg/ml BSA, 1 mg/ml collagenase, and 100 µM CaCl2 and incubated for 9 min at 37°C. The tissue was then washed three times using cold enzyme solution, and the single smooth muscle cells were isolated by several passages of the tissue pieces through the tip of a fire-polished glass Pasteur pipette. The resultant cell suspension was kept in enzyme solution at 4°C until use, generally within 6 h. All experiments involving isolated cells were performed at room temperature (22°C). The cell length was similar in the three age groups (young adult 44.68 ± 1.62, aged 45.49 ± 1.83, and melatonin 43.07 ± 1.36 µm; n = 98, 61, and 96 cells, respectively)

Cell Loading and [Ca2+]i Determination. [Ca2+]i was determined by epifluorescence microscopy using the fluorescent ratiometric Ca2+ indicator fura 2 as described previously (Morales et al., 2004Go). Isolated cells were loaded with 4 µM fura 2/AM at room temperature for 25 min. An aliquot of cell suspension was placed in an experimental chamber made with a glass poly-D-lysine-treated coverslip (0.17 mm thick) filled with Na+-HEPES solution (for composition see Solutions and Drugs) and mounted on the stage of an inverted microscope (Eclipse TE2000-S; Nikon, Melville, NY). After cell sedimentation, a gravity-fed system was used to perfuse the chamber with Na+-HEPES solution in the absence or presence of the experimental agents. Cells were illuminated at 340 and 380 nm by a computer-controlled monochromator (Optoscan; Cairn Research, Faversham, UK) at 0.3 cycle/s, and the emitted fluorescence was selected by a 510/40-nm bandpass filter. The emitted fluorescence images were captured with a cooled digital charge-coupled device camera (ORCAII-ER; Hamamatsu Photonics, Bridgewater, NJ) and recorded using dedicated software (Metafluor; Molecular Devices, Downingtown, PA). The ratio of fluorescence at 340 nm to fluorescence at 380 nm (F340/F380) was calculated pixel by pixel and used to indicate the changes in [Ca2+]i. A calibration of the ratio for [Ca2+]i was not performed in view of the many uncertainties related to the binding properties of fura 2 with Ca2+ within smooth muscle cells.

F-actin Content Measurement. The F-actin content of gallbladder smooth muscle cells was determined according to a previously published procedure (Morales et al., 2005bGo). In brief, samples of gallbladder smooth muscle cell suspensions (200 µl) in Na+-HEPES solution were transferred to 200 µl of ice-cold 3% (w/v) formaldehyde in PBS (for composition see Solution and Drugs) for 10 min. Fixed cells were permeabilized by incubation for 10 min with 0.025% (v/v) Nonidet P-40 detergent dissolved in PBS. Cells were then incubated for 30 min with fluorescein isothiocyanate-labeled phalloidin (FITC-phalloidin) (1 µM) in PBS supplemented with 0.5% (w/v) BSA. After incubation, the cells were collected by centrifugation for 2 min at 10,000g and resuspended in PBS. Staining of actin filaments was measured using a confocal laser-scanning system (model MRC-1024; Bio-Rad, Hercules, CA) with an excitation wavelength of 488 nm and emission at 515 nm. The cell F-actin content was quantified as arbitrary units of fluorescence using ImageJ software (National Institutes of Health, Bethesda, MD).

Solutions and Drugs. The Krebs-Henseleit solution contained 113 mM NaCl, 4.7 mM KCl, 2.5 mM CaCl2, 1.2 mM KH2PO4, 1.2 mM MgSO4, 25 mM NaHCO3, and 11.5 mM D-glucose. This solution had a final pH of 7.35 after equilibration with 95% O2-5% CO2. The enzyme solution used to disperse cells was made up of 10 mM HEPES, 55 mM NaCl, 5.6 mM KCl, 80 mM sodium glutamate, 2 mM MgCl2, and 10 mM D-glucose, with pH adjusted to 7.3 with NaOH. The Na+-HEPES solution contained 10 mM HEPES, 140 mM NaCl, 4.7 mM KCl, 2 mM CaCl2, 2 mM MgCl2, and 10 mM D-glucose, with pH adjusted to 7.3 with NaOH. The Ca2+-free Na+-HEPES solution was prepared by substituting EGTA (1 mM) for CaCl2. The PBS used in F-actin studies contained 137 mM NaCl, 2.7 mM KCl, 5.62 mM Na2HPO4, 1.09 mM NaH2PO4, and 1.47 mM H2PO4 with pH adjusted to 7.2. Drug concentrations are expressed as final bath concentrations of active species. Drugs and chemicals were obtained from the following sources: ACh, atropine, caffeine, CGRP fragment 8 to 37 (CGRP8–37), CCK fragment 26 to 33 (CCK-8) sulfated 1,4-dithio-DL-threitol, glibenclamide, ionomycin, L-NAME, melatonin, thapsigargin, and FITC-phalloidin were from Sigma Chemical Company (St. Louis, MO); E-capsaicin was from Tocris Cookson (Bristol, UK); Bt3-Ins(1,4,5)P3-PM was from SiChem (Bremen, Germany); fura 2/AM was from Molecular Probes Europe (Leiden, Netherlands); collagenase was from Fluka (Madrid, Spain); and papain was from Worthington Biochemical (Lakewood, NJ). Other chemicals used were of analytical grade from Panreac (Barcelona, Spain). Stock solutions of atropine, capsaicin, fura 2/AM, thapsigargin, and ionomycin were prepared in DMSO, and FITC-phalloidin was prepared in ethanol. The solutions were diluted such that the final concentration of DMSO was ≤0.1% v/v. This concentration of DMSO did not interfere with fura 2 fluorescence. Melatonin was prepared in 80 mM glucose solution.


Figure 1
View larger version (26K):
[in this window]
[in a new window]
 
Fig. 1. Neuromuscular transmission is impaired in aging and restored by melatonin. A, original recordings showing tension responses elicited by EFS (0.3-ms duration pulse, 5–40 Hz, 350 mA, for 10 s every 3 min) applied to gallbladder strips from young adult, aged, and aged guinea pigs treated with 2.5 mg/kg/day melatonin. Short bars indicate the timing of different frequency stimulations. Traces are typical of 15 to 26 strips. B, superimposed recordings of the EFS-induced response to 25 Hz showing in more details the aging-related reduction in the peak amplitude and duration of the response. In addition, the long-lasting off relaxation can be observed in the recording corresponding to aged strips. Note that melatonin treatment reverted EFS-induced responses to normal, indicating the restoration of neuromuscular transmission in these animals. C, summary data of the EFS-induced responses (peak amplitude) expressed as the percentage of the response to 10 µM ACh. When expressed in this way EFS-elicited contractions are higher in aged strips (P < 0.0001, by ANOVA).

 
Quantification and Statistics. Results are expressed as means ± S.E.M. of n cells or gallbladder strips. Gallbladder tension is given in millinewtons per milligram of tissue. All results from [Ca2+]i determinations are given as {Delta}F340/F380. Statistical differences between means were determined by Student's t test. Differences between multiple groups were tested using two-way analysis of variance (ANOVA) followed by a Bonferroni's post hoc test. Differences were considered significant at P < 0.05.


    Results
 Top
 Abstract
 Materials and Methods
 Results
 Discussion
 References
 
Age-Related Changes in Efferent Innervation in EFS-Induced Gallbladder Responses. EFS induced a frequency-dependent gallbladder contraction (a representative trace is shown in Fig. 1A) with a maximal amplitude of 2.23 ± 0.18 mN/mg tissue at the frequency of 40 Hz (n = 26) (Table 1). When gallbladder strips from aged animals were electrically stimulated, a significant decrease in the EFS-induced contraction at all of the frequencies tested was recorded (Fig. 1A; Table 1). The diminished response was reflected by reductions in both the amplitude of the peak and the duration of the contraction (P < 0.001, two-way ANOVA for both parameters) (Fig. 1B; Table 1). In addition, there was a long-lasting off-relaxation (amplitude of 0.245 ± 0.025 mN/mg at 40 Hz, n = 22) in the strips from older animals, but not in the younger animals.


View this table:
[in this window]
[in a new window]
 
TABLE 1 EFS-induced gallbladder contractions: effects of aging and melatonin treatment

 

A group of old animals was treated orally with melatonin (2.5 mg/kg/day) for 4 weeks, mimicking the circadian rhythm of the naturally secreted hormone. This treatment increased melatonin blood levels in aged animals when measured at 9:00 AM (young adult 26.24 ± 2.12, aged 19.6 ± 1.48, and melatonin 27.09 ± 2.29 pg/ml; n = 10, 7, and 7 animals, respectively, P < 0.05 aged versus young adult and aged versus melatonin). Melatonin treatment ameliorated age-induced impairment in the EFS response as both the amplitude and duration of EFS-induced contractions were comparable with those in young adult strips, and the off-relaxations were absent (Fig. 1, A and B; Table 1).

The aged-related impairment in gallbladder contractility could involve changes in the intrinsic innervation of the organ, alterations in the smooth muscle contractility itself, or a combination of these mechanisms. The gallbladder contractile response to exogenous ACh was significantly reduced in aged animals (young adult 3.266 ± 0.260, aged 1.911 ± 0.27, and melatonin 4.232 ± 0.538 mN/mg; n = 29, 15, and 11 strips, respectively, P < 0.001 aged versus young adult and aged versus melatonin), suggesting an age-related impairment in the myogenic response to the neurotransmitter released from intrinsic nerves. By taking into account the fact that ACh is the primary excitatory neurotransmitter in the gallbladder (Parkman et al., 1997Go), the expression of an EFS-induced response to ACh-induced contraction would reflect the amount of ACh released. As shown in Fig. 1C, the EFS-induced response expressed in this way is higher in strips from aged animals (P < 0.001 by ANOVA), which would indicate an increase in the release of ACh or a decrease in the release of inhibitory neurotransmitters. An increase in the release of ACh does not seem probable as the effect of atropine was not different in young adult, aged, or melatonin-treated aged strips (Fig. 2; Table 2).


Figure 2
View larger version (23K):
[in this window]
[in a new window]
 
Fig. 2. Atropine-sensitive EFS-induced response remains unaltered by aging. A, B, and C, effects of atropine (1 µM) on the frequency-response curves to EFS (0.3-ms duration pulse, 5–40 Hz, 350 mA, for 10 s every 3 min) applied to gallbladder strips from young adult (n = 24 strips), aged (n = 21 strips), and aged guinea pigs treated with 2.5 mg/kg/day melatonin (n = 10 strips). After EFS was performed in control conditions (——) strips were incubated for 30 min with atropine and EFS was repeated again (· · · ·). Statistical analysis indicates P <0.001 (by ANOVA) in all experimental groups. D, atropineinduced inhibition of EFS responses in the three experimental groups. No significant differences between groups were found at any of the frequencies tested.

 

View this table:
[in this window]
[in a new window]
 
TABLE 2 Effects of different drugs on EFS-evoked gallbladder contractions

 

To explore the possibility of an age-induced change in the release of inhibitory neurotransmitters, we assayed the effects of L-NAME in each experimental group. The inhibitor of the nitric-oxide synthase enhanced EFS-induced contraction in young adult strips (89.3% enhancement at 5 Hz, n = 10, P < 0.01 by ANOVA) but did not have any effects in the aged group (Fig. 3; Table 2). When the old animals were pretreated with melatonin, the nitrergic component was stimulated by EFS and L-NAME enhanced EFS-induced contraction (193.8% enhancement at 5 Hz, n = 5, P < 0.001, by ANOVA) (Fig. 3; Table 2).


Figure 3
View larger version (24K):
[in this window]
[in a new window]
 
Fig. 3. Nitrergic function is impaired in aging and is restored by melatonin. A, original recordings of the effects of L-NAME (100 µM) on the EFS (0.3-ms duration pulse, 5–40 Hz, 350 mA, for 10 s every 3 min) applied to gallbladder strips from young adult, aged, and aged guinea pigs treated with 2.5 mg/kg/day melatonin. After EFS was performed in control conditions, strips were incubated for 30 min with L-NAME, and EFS was repeated again. Vertical dotted lines indicate the timing of EFS. B, summary data of the frequency-response curves to EFS. Data are means ± S.E.M. n = 10, 6, and 5 strips for adult, aged, and aged treated with melatonin, respectively. Note that L-NAME does not have effects on aged gallbladder strips, indicating the loss of nitrergic function and the fact that melatonin treatment induces the recovery of the nitrergic responses. P < 0.01 and P < 0.001 (by ANOVA) control versus L-NAME for young adult and aged + melatonin experimental groups.

 

Age-Related Changes in Sensory Innervation. In our model, when the sensory nerves were desensitized by the treatment with a high concentration of capsaicin (10 µM), a transient atropine-sensitive contraction was recorded in both young adult and old strips (adult 0.081 ± 0.016 and aged 0.100 ± 0.016 mN/mg; n = 8 and 6 strips, respectively), but there was no change in EFS-induced responsiveness of young adult strips (Fig. 4; Table 2). However, when aged strips were desensitized by capsaicin a significant increase in the EFS-induced response was recorded (P < 0.01 by ANOVA). As shown in Fig. 4, melatonin treatment restored the excitability of the sensory innervation, because capsaicin had no effect on EFS-induced responses (Table 2). CGRP induces gallbladder relaxation through stimulation of KATP ion channels and glibenclamide has been shown to be an effective blocker of these channels in the gallbladder (Zhang et al., 1994Go). Thus, we assayed the effects of 10 µM glibenclamide on the EFS-induced response in aged strips, which enhanced the amplitude of contraction to an extent similar to the desensitization with capsaicin (25% increase, n = 7, P < 0.05 by ANOVA) (Fig. 5, A and B; Table 2). In fact, after glibenclamide treatment capsaicin did not enhance EFS-induced responses (P = 0.18) (Fig. 5, A and B; Table 2). In agreement with the lack of effects of capsaicin in neuromuscular transmission in adult strips, glibenclamide did not modify EFS-induced responses in control tissue (data not shown). These experiments suggest that, in aging, EFS stimulates CGRP-containing sensory nerves, which could contribute to the reduction of gallbladder responsiveness to electrical stimuli via physiological antagonism. This finding was confirmed by the use of the fragment CGRP8–37 as selective blocker of CGRP receptors. As shown in Fig. 5, in senescent gallbladder strips CGRP8–37 caused an enhancement of EFS-induced contraction (41.9% increase, n = 4, P < 0.05 by ANOVA) (Fig. 5, A and B; Table 2) and converted the effect of capsaicin to an inhibition of the contractile response (37% inhibition respect to CGRP8–37 alone, n = 4, P < 0.01 by ANOVA) (Fig. 5, A and B; Table 2).


Figure 4
View larger version (25K):
[in this window]
[in a new window]
 
Fig. 4. Aging induces sensitization of inhibitory sensory afferent fibers and melatonin normalizes their sensitivity. A, original recordings of the effects of capsaicin (10 µM) on the EFS (0.3-ms duration pulse, 5–40 Hz, 350 mA, for 10 s every 3 min) applied to gallbladder strips from young adult, aged and aged guinea pigs treated with 2.5 mg/kg/day melatonin. After EFS was performed in control conditions, strips were incubated for 30 min with capsaicin, and EFS was repeated again. Vertical dotted lines indicate the timing of EFS. B, summary data of the frequency-response curves to EFS. Data are means ± S.E.M. n = 8, 6, and 4 strips for young adult, aged, and aged treated with melatonin, respectively. Note that capsaicin increases the EFS-induced contraction only in aged gallbladder strips, indicating sensitization of the inhibitory component of sensory fibers and reversal of this sensitization by melatonin treatment. P < 0.01 (by ANOVA), control versus capsaicin in aged strips.

 

Figure 5
View larger version (21K):
[in this window]
[in a new window]
 
Fig. 5. Aging sensitizes CGRP containing fibers. A, original recordings of the effects of glibenclamide (10 µM) and CGRP8–37 in the absence and presence of capsaicin (10 µM) on the EFS (0.3-ms duration pulse, 5–40 Hz, 350 mA, for 10 s every 3 min) applied to aged gallbladder strips. After EFS was performed in control conditions, strips were incubated for 30 min with glibenclamide or CGRP8–37 and EFS was repeated again. Then, strips were incubated for 30 min with glibenclamide or CGRP8–37 plus capsaicin, and EFS was repeated again. Vertical dotted lines indicate the timing of EFS. B, summary data of the frequency-response curves to EFS in the presence and absence of glibenclamide or CGRP8–37 and glibenclamide or CGRP8–37 plus capsaicin. Data are means ± S.E.M. n = 7 and 4 strips for the glibenclamide and capsaicin groups, respectively. Note that both drugs have a stimulatory effect and after the treatment with glibenclamide or CGRP8–37 capsaicin does not increase EFS-induced contractions. P < 0.05 (by ANOVA), control versus glibenclamide and control versus CGRP8–37.

 
Age-Related Changes in Gallbladder Contractility. To explore how aging affects Ca2+ influx-mediated contractions, we used voltage-activated calcium entry induced by 60 mM KCl, which produced a sustained contraction that was significantly reduced (24.8% reduction) when we tested gallbladder strips from aged animals and recovered by melatonin treatment (young adult 3.77 ± 0.37, aged 2.84 ± 0.26, and melatonin 4.24 ± 0.32 mN/mg; n = 26; 23 and 9 strips, respectively, P < 0.05) (Fig. 6). We have recently shown that capacitative calcium entry (CCE) is another influx route activating contraction in gallbladder smooth muscle (Morales et al., 2004Go). As previously reported, after depletion of the stores by incubation of control gallbladder strips with 1 µM TPS in Ca2+-free medium for 30 min, reintroduction of extracellular Ca2+ induced a sustained contraction (3.69 ± 0.53 mN/mg; n = 12) that was significantly smaller in aged strips (2.68 ± 0.29 mN/mg; n = 9, P < 0.01) but similar in melatonin-treated animals (4.41 ± 0.39 mN/mg; n = 8) (Fig. 6B).


Figure 6
View larger version (27K):
[in this window]
[in a new window]
 
Fig. 6. Melatonin (ML) restores gallbladder myogenic contractility. A, representative original traces of changes in isometric tension in response to a depolarizing solution containing 60 mM KCl in young adult (——), aged (– – –) and aged treated with melatonin (· · · ·) gallbladder strips. B, gallbladder strips were treated with 1 µM TPS in Ca2+-free solution to deplete the stores. When indicated, the organ bath was perfused with a 2 mM Ca2+ Krebs-Henseleit solution, resulting in a sustained contraction that was reduced in aged strips (– – –). C, contraction was induced by 10 nM CCK in all groups. Note that the response to all of the stimuli was decreased in aged cells, but melatonin treatment induced the recovery of the contractility. Traces are typical of nine to 30 strips. Histograms show summary data tension (millinewtons per milligram) from experiments in the above-described conditions (means ± S.E.M.). D, age-related changes in F-actin content (expressed as arbitrary units) in young adult, aged, and aged plus melatonin-treated gallbladder cells. Note the decrease in F-actin content in aged cells and the recovery when the aged animals were treated with melatonin. *, P < 0.05; **, P < 0.01.

 

To test whether aging affects Ca2+ release from sarcoplasmic reticulum, the main intracellular Ca2+ store in gallbladder smooth muscle (Morales et al., 2005aGo), we used CCK as the tool of election. As was the case for Ca2+ influx-induced contractions, CCK-induced contraction was impaired in aged strips and melatonin treatment recovered contractility (young adult 3.7 ± 0.38, aged 2.48 ± 0.25, and melatonin 3.67 ± 0.52 mN/mg; n = 30, 23, and 9 strips, respectively, P < 0.01) (Fig. 6C).

Age-Related Changes in Calcium Handling. The diminished contractile response to Ca2+ influx could be the result of the reduction in the calcium entry as a consequence of age-mediated calcium channel impairment. To test this possibility, we quantified [Ca2+]i in response to 60 mM KCl and to the protocol to activate capacitative calcium entry. As represented in Fig. 7, A and B, a sustained [Ca2+]i plateau due to Ca2+ entry from the extracellular medium was reduced in aged gallbladder smooth muscle cells (26.2 and 34.2% reduction for KCl and CCE, respectively; n = 18 to 49 cells, P < 0.05). Interestingly, melatonin did not have any effects on calcium influx (KCl: 0.111 ± 0.008 versus 0.115 ± 0.010 {Delta}F340/F380, n = 34 and 13 cells for aged and melatonin-treated aged cells, respectively; CCE: 0.063 ± 0.005 versus 0.067 ± 0.007 {Delta}F340/F380, n = 8 and 6 cells).


Figure 7
View larger version (21K):
[in this window]
[in a new window]
 
Fig. 7. Aging reduces Ca2+ influx but not Ca2+ release from intracellular stores. A, representative original traces of changes in the fluorescence ratio in response to a depolarizing solution containing 60 mM KCl and 2 mM Ca2+ in young adult (——) and aged (· · · ·) cells. As observed, aging reduced the plateau response. In B, fura 2-loaded cells were treated with 1 µM TPS in Ca2+ free solution to deplete the stores. When indicated, cells were perfused with a 2 mM Ca2+ HEPES solution resulting in a sustained [Ca2+]i increase that was reduced in aged cells (· · · ·). C and D, Ca2+ release from intracellular stores was induced by 10 nM CCK (IP3-sensitive stores) or caffeine (ryanodine-sensitive stores), respectively. Note that the peak, indicative of Ca2+ release, was similar in both young adult and aged cells, but the plateau, indicative of Ca2+ entry was reduced in senescent cells. Traces are typical of 15 to 49 cells from at least four to five independent experiments Histograms show summary data for {Delta}F340/F380 from experiments in the above-described conditions (means ± S.E.M.). *, P < 0.05; **, P < 0.01.

 
When we quantified [Ca2+]i in response to a CCK challenge, there was no change in the amplitude of the Ca2+ transient peak, indicative of intracellular Ca2+ release (n = 28 and 15 cells, P = 0.897) (Fig. 7C). To confirm that Ca2+ release from stores through D-myo-inositol 1,4,5-triphosphate (IP3) and ryanodine channels remained unchanged in aging, we exposed the cells to 10 µM Bt3-Ins(1,4,5)P3-PM, a membrane permeable analog of IP3 and to caffeine. Similar to the CCK-induced Ca2+ transient, the peak responses to the IP3 analog were not affected by aging (young adult 0.426 ± 0.031 and aged 0.379 ± 0.028 {Delta}F340/F380; n = 13 and 7 cells, respectively, P = 0.272). When we used caffeine to induce Ca2+ release through ryanodine receptors, we did not detect a difference in the Ca2+ transient in young adult versus aged gallbladder smooth muscle cells (n = 31 and 36 cells, P = 0.412) (Fig. 7D). Collectively, these results suggest that both Ca2+ release channels and calcium content in the stores are not affected by aging. The latter result was confirmed by application of a low level of ionomycin in Ca2+-free solution to the cells, a treatment that releases the Ca2+ stores while bypassing channels and receptors. This treatment caused a similar increase in [Ca2+]i in both adult and aged cells (young adult 0.188 ± 0.029 and aged 0.180 ± 0.015 {Delta}F340/F380; n = 14 and 24 cells, respectively, P = 0.821), indicating that the integrity of calcium stores is preserved in aging. Melatonin treatment did not have any effect on Ca2+ release mechanisms nor on Ca2+ store content (data not shown)

Age-Related Changes in Contractile Machinery. Taken together, the results described above indicate that the age impairment in contractility is, at least in part, the result of alterations in Ca2+ influx, but this physiological condition could also alter gallbladder contractility independently of the calcium signal. This possibility was tested by application of 1 µM ionomycin in presence of extracellular Ca2+ (at this concentration ionomycin raises [Ca2+]i independently of channels and receptors). Ionomycin caused similar elevations in adult, aged, and melatonin-treated cells (young adult 0.355 ± 0.050, aged 0.419 ± 0.052, and melatonin 0.376 ± 0.057 {Delta}F340/F380; n = 32, 30, and 16 cells, respectively, P > 0. 05) but induced much lower contraction in aged strips than in adult and melatonin-treated aged tissues (young adult 4.23 ± 0.57, aged 2.12 ± 0.201, and melatonin 5.39 ± 0.87 mN/mg; n = 7, 14, and 8 strips, respectively, P < 0.01 young adult versus aged), suggesting that aging can also alter the contractile machinery independently of the calcium signal.

To investigate one of the possible causes of this impaired contractility, we determined the total amount of the contractile protein F-actin by labeling gallbladder smooth muscle cells with FITC-stained phalloidin. We found that aging resulted in a statistically significant decrease in the F-actin content that was recovered by melatonin treatment (young adult 33.59 ± 0.86, aged 9.92 ± 0.49, and melatonin 28.95 ± 0.87 arbitrary units of fluorescence; n = 100, 63, and 92 cells, respectively, P < 0.05 young adult versus aged (Fig. 6D).


    Discussion
 Top
 Abstract
 Materials and Methods
 Results
 Discussion
 References
 
At a time when the world population is aging at a rapid rate, there is an emergent need to understand the biology of the aged GI tract and to translate this knowledge to therapeutics to improve GI function and quality of life of elderly persons. The present study was conducted to elucidate functional changes in gallbladder motility during aging and to explore the potential use of melatonin to ameliorate the onslaught of aging on GI structures.

We found that aging impairs muscular contraction and modifies neurological control of muscle. The possibility that altered GI function in elderly persons is related to neurodegeneration of the enteric nervous system is supported by studies conducted both in animals and humans (for review, see Wade and Cowen, 2004Go). Age-related neuronal loss in the small and large intestines occurs exclusively in the cholinergic population (Roberts et al., 1994Go; Phillips et al., 2003Go), with little change, if any, in nitrergic neurons. However, in the gallbladder, cholinergic transmission appears very well maintained with age, because the atropine-sensitive contractile response to EFS remains the same in the adult and aged groups. Our finding of a decrease in the functionality of nitrergic fibers in the aged group can be related to previous reports of morphological alterations in nitrergic neurons (Phillips et al., 2003Go) and impaired nitrergic function by aging (Smits and Lefebvre, 1996Go), which is consistent with our functional studies.

Interestingly, in our model, the loss of nitrergic inhibitory function was compensated for by over-reactivity of sensory inhibitory nerves, as demonstrated by the increase in the EFS-induced contraction after desensitization with capsaicin. The ganglionated plexus of the gallbladder is rich in afferent fibers that are immunoreactive for both substance P and CGRP (Mawe and Gershon, 1989Go). Application of capsaicin induced a contractile response that was the result of the substance P-induced contraction and CGRP-induced relaxation (Maggi et al., 1989Go), similar to our finding of capsaicinevoked contraction sensitive to atropine. However, capsaicin desensitization of sensory nerves increased the EFS-induced responses in aged strips without affecting adult strips. The fact that capsaicin effects were mediated by the CGRP1 receptor (blocked by human CGRP8–37) and its downstream target KATP channels (blocked by glibenclamide) clearly suggests that hypersensitivity of inhibitory sensory fibers containing CGRP contribute to gallbladder motility disorders in aging. It is now clear that hypersensitivity of sensory neurons contributes to functional bowel disorders such as irritable bowel syndrome, Hirschsprung's disease, rectal hypersensitivity, and fecal urgency (Grundy, 2006Go).

Motility disorders during aging can also involve age-dependent changes in the response of smooth muscle to neurotransmitters and hormones (for review, see Bitar, 2003Go) due to inhibition of transduction pathways or to alterations of contractile proteins (Bitar, 2003Go; Bitar and Patil, 2004Go). We report here both changes in Ca2+ signals and a decrease in the F-actin content in aged gallbladder smooth muscle cells. Our study shows that aging affects Ca2+ entry through both L-type Ca2+ channels and store-operated Ca2+ channels, although the content of intracellular Ca2+ stores and Ca2+ release through IP3 and ryanodine receptors is not influenced. Age-related changes in Ca2+ homeostasis seem to be tissue-specific. Thus, reduction of voltage-dependent calcium channels has been described in rat brain cortices (Iwamoto et al., 2004Go), canine atria (Dun et al., 2003Go), and colon (Xiong et al., 1993Go, 1995Go), but voltage-activated Ca2+ influx is increased in mammalian CA1 hippocampal neurons (Thibault and Landfield, 1996Go) and heart (Josephson et al., 2002Go) during aging. There are no published data related to the effects of aging on CCE channels. Our data are consistent with the hypothesis that in gallbladder smooth muscle aging mainly affects membrane L-type and CCE Ca2+ channels, which could contribute to the reduction in contractility in response to KCl, CCE, but also to CCK, as this hormone induces Ca2+ entry after releasing Ca2+ from intracellular stores (Morales et al., 2004Go, 2005aGo).

One of the most compelling findings reported here is the beneficial effect of melatonin on gallbladder neuromuscular function and myogenic contractility. Thus, after treating the animals for 4 weeks with melatonin (2.5 mg/kg/day), there was not only a total recovery of the contractile response to Ca2+ influx activation and EFS but also a reversion of the aged-induced changes in efferent and sensitive innervation, although melatonin did not restore the Ca2+ influx. The recovery of the contractility without changes in Ca2+ homeostasis can only be explained by effects of melatonin on Ca2+-insensitive contractility steps such as contractile proteins or Ca2+ sensitization of the contractile machinery. Whereas the former can be related to the increase in the F-actin content described in this study, the later is now under research in our laboratory.

Melatonin is a hormone that is secreted by the pineal gland following a circadian rhythm with minimal blood levels of melatonin during the daytime and maximal levels observed mostly during the middle of the night. Melatonin has special importance in the gastrointestinal tract because the enterochromaffin cells of the gut are the main source of extrapineal melatonin (Kvetnoy et al., 2002Go). Metabolism of melatonin in liver seems to be the major metabolic pathway for its deactivation (Lane and Moss, 1985Go), but active melatonin is also secreted in bile and concentrated in the gallbladder (Tan et al., 1999Go). Although it is well established that pineal melatonin decreases with age (Karasek, 2004Go), there is no information available regarding gastrointestinal melatonin. If gastrointestinal melatonin content also decreases with age, the hepatobiliary system in general and the gallbladder in particular would because of the lack of melatonin protective effects. The restoration of gallbladder contractility in response to melatonin treatment in aged guinea pigs is consistent with this hypothesis.

Regarding the GI tract, there are numerous lines of evidence demonstrating the protective and healing effects of melatonin in gastric ulcers and experimental colitis. Whereas a direct antioxidative effect, activation of CO3H secretion by enterocytes, and release of endogenous prostaglandins mediates these protective effects, the healing effect was associated with production of endogenous nitric oxide and participation of sensory nerves (for review, see Reiter et al., 2003Go). The effects of melatonin on symptoms of colitis are related to decreases in nitric oxide and prostaglandin E2 content as the result of down-regulated expression of colonic inducible nitric-oxide synthase and cycloxygenase-2 (Dong et al., 2003Go) in addition to an enhancement of the immune response in the gastrointestinal tract (Mei et al., 2002Go). The present study is the first report on the beneficial effects of melatonin treatment in aged gastrointestinal tract, but more studies are required to establish the cellular mechanisms through which melatonin exerts its effects in the gallbladder and the optimal pattern of melatonin treatment to ameliorate the effects of aging. Both lines of research will elucidate the potential use of melatonin in elderly population.

In conclusion, our results indicate that aging causes impairment of gallbladder function as consequence of neurally mediated and neurally independent mechanisms and support a possible beneficial effect of melatonin in gallbladder dysfunction related to aging.


    Acknowledgements
 
We thank Gary M. Mawe for critical reading of the manuscript and Purificación Delgado for technical assistance.


    Footnotes
 
This work was supported by Junta de Extremadura (2PR03A020) and Ministerio de Educacion y Ciencia (BFU 2004–0637). P.J.G.-P. is the recipient of a doctoral fellowship from Junta de Extremadura.

Article, publication date, and citation information can be found at http://jpet.aspetjournals.org.

doi:10.1124/jpet.106.109256.

ABBREVIATIONS: GI, gastrointestinal; EFS, electrical field stimulation; ACh, acetylcholine; CCK, cholecystokinin; BSA, bovine serum albumin; AM, acetoxymethyl ester; PBS, phosphate-buffered saline; FITC-phalloidin, fluorescein isothiocyanate-labeled phalloidin; CGRP, calcitonin gene-related peptide; L-NAME, N{omega}-nitro-L-arginine methyl ester; CCK-8, CCK fragment 26 to 33; Bt3-Ins(1,4,5)P3-PM, 2,3,6-tri-O-butyryl-myoinositol-1,4,5-trisphosphate-hexakis(propionoxymethyl) ester; ANOVA, analysis of variance; CCE, capacitative calcium entry; TPS, thapsigargin; IP3, D-myo-inositol 1,4,5-triphosphate.

Address correspondence to: Dr. Maria J. Pozo, Department of Physiology, Nursing School, Avda Universidad s/n, 10071 Cáceres, Spain. E-mail: mjpozo{at}unex.es


    References
 Top
 Abstract
 Materials and Methods
 Results
 Discussion
 References
 

Bailey AJ (2001) Molecular mechanisms of ageing in connective tissues. Mech Ageing Dev 122: 735–755.[CrossRef][Medline]
Bitar KN (2003) Aging and neural control of the GI tract. V. Aging and gastrointestinal smooth muscle: from signal transduction to contractile proteins. Am J Physiol 284: G1–G7.
Bitar KN and Patil SB (2004) Aging and gastrointestinal smooth muscle. Mech Ageing Dev 125: 907–910.[CrossRef][Medline]
Camilleri M, Lee JS, Viramontes B, Bharucha AE, and Tangalos EG (2000) Insights into the pathophysiology and mechanisms of constipation, irritable bowel syndrome, and diverticulosis in older people. J Am Geriatr Soc 48: 1142–1150.[Medline]
Centers for Disease Control And Prevention (2003) Trends in aging—United States and worldwide. MMWR Morb Mortal Wkly Rep 52: 101–104, 106.[Medline]
Dong WG, Mei Q, Yu JP, Xu JM, Xiang L, and Xu Y (2003) Effects of melatonin on the expression of iNOS and COX-2 in rat models of colitis. World J Gastroenterol 9: 1307–1311.[Medline]
Dun W, Yagi T, Rosen MR, and Boyden PA (2003) Calcium and potassium currents in cells from adult and aged canine right atria. Cardiovasc Res 58: 526–534.[Abstract/Free Full Text]
Ferrari AU, Radaelli A, and Centola M (2003) Invited review: aging and the cardiovascular system. J Appl Physiol 95: 2591–2597.[Abstract/Free Full Text]
Gomes OA, de Souza RR, and Liberti EA (1997) A preliminary investigation of the effects of aging on the nerve cell number in the myenteric ganglia of the human colon. Gerontology 43: 210–217.[Medline]
Grundy D (2006) Signalling the state of the digestive tract. Auton Neurosci 125: 76–80.[CrossRef][Medline]
Iwamoto M, Hagishita T, Shoji-Kasai Y, Ando S, and Tanaka Y (2004) Age-related changes in the levels of voltage-dependent calcium channels and other synaptic proteins in rat brain cortices. Neurosci Lett 366: 277–281.[CrossRef][Medline]
Josephson IR, Guia A, Stern MD, and Lakatta EG (2002) Alterations in properties of L-type Ca channels in aging rat heart. J Mol Cell Cardiol 34: 297–308.[CrossRef][Medline]
Karasek M (2004) Melatonin, human aging, and age-related diseases. Exp Gerontol 39: 1723–1729.[CrossRef][Medline]
Kvetnoy IM, Ingel IE, Kvetnaia TV, Malinovskaya NK, Rapoport SI, Raikhlin NT, Trofimov AV, and Yuzhakov VV (2002) Gastrointestinal melatonin: cellular identification and biological role. Neuro Endocrinol Lett 23: 121–132.[Medline]
Lane EA and Moss HB (1985) Pharmacokinetics of melatonin in man: first pass hepatic metabolism. J Clin Endocrinol Metab 61: 1214–1216.[Abstract/Free Full Text]
Maggi CA, Santicioli P, Renzi D, Patacchini R, Surrenti C, and Meli A (1989) Release of substance P- and calcitonin gene-related peptide-like immunoreactivity and motor response of the isolated guinea pig gallbladder to capsaicin. Gastroenterology 96: 1093–1101.[Medline]
Mawe GM and Gershon MD (1989) Structure, afferent innervation, and transmitter content of ganglia of the guinea pig gallbladder: relationship to the enteric nervous system. J Comp Neurol 283: 374–390.[CrossRef][Medline]
Mei Q, Yu JP, Xu JM, Wei W, Xiang L, and Yue L (2002) Melatonin reduces colon immunological injury in rats by regulating activity of macrophages. Acta Pharmacol Sin 23: 882–886.[Medline]
Morales S, Camello PJ, Alcon S, Salido GM, Mawe G, and Pozo MJ (2004) Coactivation of capacitative calcium entry and L-type calcium channels in guinea pig gallbladder. Am J Physiol 286: G1090 –G1100.
Morales S, Camello PJ, Mawe GM, and Pozo MJ (2005a) Characterization of intracellular Ca2+ stores in gallbladder smooth muscle. Am J Physiol 288: G507–G513.
Morales S, Camello PJ, Rosado JA, Mawe GM, and Pozo MJ (2005b) Disruption of the filamentous actin cytoskeleton is necessary for the activation of capacitative calcium entry in naive smooth muscle cells. Cell Signal 17: 635–645.[CrossRef][Medline]
Nasr SZ and Ouslander JG (1998) Urinary incontinence in the elderly: causes and treatment options. Drugs Aging 12: 349–360.[CrossRef][Medline]
Parkman HP, Pagano AP, Martin JS, and Ryan JP (1997) Electric field stimulation-induced guinea pig gallbladder contractions: role of calcium channels in acetylcholine release. Dig Dis Sci 42: 1919–1925.[CrossRef][Medline]
Phillips RJ, Kieffer EJ, and Powley TL (2003) Aging of the myenteric plexus: neuronal loss is specific to cholinergic neurons. Auton Neurosci 106: 69–83.[CrossRef][Medline]
Pozo MJ, Perez GJ, Nelson MT, and Mawe GM (2002) Ca2+ sparks and BK currents in gallbladder myocytes: role in CCK-induced response. Am J Physiol 282: G165–G174.
Reiter RJ, Pablos MI, Agapito TT, and Guerrero JM (1996) Melatonin in the context of the free radical theory of aging. Ann NY Acad Sci 786: 362–378.[Medline]
Reiter RJ, Tan DX, Manchester LC, and El Sawi MR (2002) Melatonin reduces oxidant damage and promotes mitochondrial respiration: implications for aging. Ann NY Acad Sci 959: 238–250.[Medline]
Reiter RJ, Tan DX, Mayo JC, Sainz RM, Leon J, and Bandyopadhyay D (2003) Neurally-mediated and neurally-independent beneficial actions of melatonin in the gastrointestinal tract. J Physiol Pharmacol 54 (Suppl 4): 113–125.
Roberts D, Gelperin D, and Wiley JW (1994) Evidence for age-associated reduction in acetylcholine release and smooth muscle response in the rat colon. Am J Physiol 267: G515–G522.
Smits GJ and Lefebvre RA (1996) Influence of age on cholinergic and inhibitory nonadrenergic noncholinergic responses in the rat ileum. Eur J Pharmacol 303: 79–86.[CrossRef][Medline]
Sohal RS and Allen RG (1990) Oxidative stress as a causal factor in differentiation and aging: a unifying hypothesis. Exp Gerontol 25: 499–522.[CrossRef][Medline]
Tan D, Manchester LC, Reiter RJ, Qi W, Hanes MA, and Farley NJ (1999) High physiological levels of melatonin in the bile of mammals. Life Sci 65: 2523–2529.[CrossRef][Medline]
Thibault O and Landfield PW (1996) Increase in single L-type calcium channels in hippocampal neurons during aging. Science (Wash DC) 272: 1017–1020.[Abstract]
Troulinaki K and Tavernarakis N (2005) Neurodegenerative conditions associated with ageing: a molecular interplay? Mech Ageing Dev 126: 23–33.[CrossRef][Medline]
Wade PR and Cowen T (2004) Neurodegeneration: a key factor in the ageing gut. Neurogastroenterol Motil 16 (Suppl 1): 19–23.
Winer N and Sowers JR (2004) Epidemiology of diabetes. J Clin Pharmacol 44: 397–405.[Abstract/Free Full Text]
Xiong Z, Sperelakis N, Noffsinger A, and Fenoglio-Preiser C (1993) Changes in calcium channel current densities in rat colonic smooth muscle cells during development and aging. Am J Physiol 265: C617–C625.
Xiong Z, Sperelakis N, Noffsinger A, and Fenoglio-Preiser C (1995) Ca2+ currents in human colonic smooth muscle cells. Am J Physiol 269: G378 –G385.
Zhang L, Bonev AD, Nelson MT, and Mawe GM (1994) Activation of ATP-sensitive potassium currents in guinea-pig gall-bladder smooth muscle by the neuropeptide CGRP. J Physiol (Lond) 478: 483–491.[Abstract/Free Full Text]




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
P. J. Gomez-Pinilla, P. J. Camello, and M. J. Pozo
Effects of Melatonin on Gallbladder Neuromuscular Function in Acute Cholecystitis
J. Pharmacol. Exp. Ther., October 1, 2007; 323(1): 138 - 146.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
P. J. Gomez-Pinilla, M. J. Pozo, and P. J. Camello
Aging impairs neurogenic contraction in guinea pig urinary bladder: role of oxidative stress and melatonin
Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2007; 293(2): R793 - R803.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.106.109256v1
319/2/847    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gomez-Pinilla, P. J.
Right arrow Articles by Pozo, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gomez-Pinilla, P. J.
Right arrow Articles by Pozo, M. J.


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition